Hepion Pharmaceuticals, Inc.
NASDAQ:HEPA
0.4601 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.067 | 0.077 | 0.086 | 0.035 | 0.027 | 0.019 | 0.022 | 0 | 0.022 | 0.016 | 0 | 0 |
| Gross Profit
| -0.067 | -0.077 | -0.086 | -0.035 | -0.027 | -0.019 | -0.022 | 0 | -0.022 | -0.016 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 35.64 | 33.269 | 20.395 | 11.997 | 3.184 | 7.594 | 14.327 | 13.652 | 15.019 | 8.404 | 0.314 | 0.735 |
| General & Administrative Expenses
| 9.618 | 10.348 | 10.008 | 8.149 | 4.586 | 7 | 7.278 | 7.372 | 5.786 | 5.556 | 1.358 | 0.106 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | -0.584 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.618 | 10.348 | 10.008 | 8.149 | 4.586 | 7 | 6.694 | 7.372 | 5.786 | 5.556 | 1.358 | 0.106 |
| Other Expenses
| 3.19 | 0 | 0 | 0 | -0.18 | -0.109 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 48.448 | 43.618 | 30.403 | 20.146 | 7.77 | 14.594 | 21.021 | 21.024 | 20.805 | 13.96 | 1.672 | 0.841 |
| Operating Income
| -48.448 | -45.489 | -30.403 | -20.146 | -7.77 | -14.594 | -21.043 | -21.024 | -20.805 | -13.96 | -1.672 | -0.841 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.887 | 0.405 | -2.319 | -0.177 | -0.176 | 4.609 | 2.126 | 4.225 | 3.807 | -0.388 | -3.609 | -0.002 |
| Income Before Tax
| -49.335 | -45.084 | -32.722 | -20.323 | -7.946 | -9.985 | -18.918 | -16.799 | -16.999 | -14.348 | -5.281 | -0.843 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.409 | -2.884 | 0.009 | 0.031 | -0.909 | -0.536 | -3.896 | -1.908 | -3.807 | 0.388 | 3.609 | -0.002 |
| Net Income
| -48.926 | -42.2 | -32.722 | -20.354 | -7.037 | -9.449 | -15.022 | -14.891 | -16.999 | -14.348 | -5.281 | -0.843 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -12.32 | -11.07 | -9.31 | -42.06 | -68.88 | -1,027.88 | -2,173.01 | -2,861.46 | -7,035.86 | -7,388.2 | -4,616.12 | -25.55 |
| EPS Diluted
| -12.32 | -11.07 | -9.31 | -42.06 | -68.88 | -1,027.88 | -2,173.01 | -2,859.26 | -7,035.86 | -7,388.2 | -4,616.12 | -25.55 |
| EBITDA
| -49.258 | -43.54 | -30.317 | -20.112 | -7.743 | -14.575 | -20.62 | -21.024 | -20.805 | -13.944 | -1.671 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |